Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survival
暂无分享,去创建一个
T. Braun | S. Choi | J. Magenau | E. Gatza | D. Bixby | P. Reddy | Anthony J. Perissinotti | B. Marini | D. Frame | T. Churay | B. Parkin | Grant Chappell | J. Brisson | M. Geer